Replies to post #249962 on Anavex Life Sciences Corp (AVXL)

[Investor2014]

the upcoming quarter will be the announcement of top-line data after Phase 2 Parkinson’s disease dementia study.

Counting from the quarter we and Missling is currently in, the public announcement of top-line data will be in Q3.

The very beginning of Q3 would be mid 2020 e.g. 1st July, but it could be in September sometime and still be in Q3.

[rocalinda]

That is really something we can put on everybody's calendar because the trial has been enrolled the last patient and we now have to wait for the 14 days – 14 weeks, which is the duration of this study plus the times needed to for the independent research zero to build the results. And then we will update the data as a – in a public announcement the top-line data, which will be mid of 2020